Get the Stockscreener App
2.96
3.90%
-0.12
After Hours:
3.09
0.13
+4.39%
Achieve Life Sciences Inc stock is traded at $2.96, with a volume of 517.36K.
It is down -3.90% in the last 24 hours and up +16.08% over the past month.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
See More
Previous Close:
$3.08
Open:
$3.07
24h Volume:
517.36K
Relative Volume:
0.40
Market Cap:
$151.27M
Revenue:
-
Net Income/Loss:
$-32.94M
P/E Ratio:
-2.6667
EPS:
-1.11
Net Cash Flow:
$-24.95M
1W Performance:
-9.76%
1M Performance:
+16.08%
6M Performance:
+1.72%
1Y Performance:
-33.93%
1-Day Range:
$2.96
$3.09
1-Week Range:
$2.96
$3.30
52-Week Range:
$1.84
$5.31
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Name
Achieve Life Sciences Inc
Sector
Industry
Phone
425-686-1500
Address
22722 29TH DR. SE, SEATTLE, BC
Compare ACHV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
2.96 | 157.40M | 0 | -32.94M | -24.95M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.15 | 100.34B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
585.50 | 60.95B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.73 | 60.46B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
734.35 | 46.04B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.20 | 36.02B | 3.81B | -644.79M | -669.77M | -6.24 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-21-25 | Initiated | H.C. Wainwright | Buy |
| Nov-14-24 | Initiated | Rodman & Renshaw | Buy |
| Sep-27-24 | Initiated | Raymond James | Strong Buy |
| May-10-23 | Reiterated | Maxim Group | Buy |
| Jun-23-21 | Initiated | Oppenheimer | Outperform |
Achieve Life Sciences Inc Stock (ACHV) Latest News
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Short Interest Up 30.2% in August - MarketBeat
Can Achieve Life Sciences Inc outperform in the next rallyMarket Rally & Advanced Swing Trade Entry Alerts - خودرو بانک
Is Choice Hotels International Inc a potential multi baggerJuly 2025 Reactions & Stepwise Entry/Exit Trade Alerts - خودرو بانک
Aug Highlights: Is Achieve Life Sciences Inc forming a breakout pattern2025 Earnings Surprises & Verified Momentum Stock Alerts - خودرو بانک
Institution Moves: Is Achieve Life Sciences Inc stock influenced by commodity pricesJuly 2025 Closing Moves & Community Trade Idea Sharing - خودرو بانک
Achieve Life Sciences gets new interim chief medical officer - MSN
Surprises Report: Is Achieve Life Sciences Inc forming a breakout patternSell Signal & Growth Oriented Trading Recommendations - خودرو بانک
Achieve Life Sciences (NASDAQ:ACHV) CMO Sells $76,532.33 in Stock - MarketBeat
Insider Selling: Achieve Life Sciences (NASDAQ:ACHV) Director Sells 139,858 Shares of Stock - MarketBeat
Achieve Life Sciences (NASDAQ:ACHV) Insider Sells $38,973.90 in Stock - MarketBeat
Achieve Life Sciences (NASDAQ:ACHV) Insider Sells $57,765.58 in Stock - MarketBeat
Achieve Life Sciences, Inc. (NASDAQ:ACHV) Sees Large Growth in Short Interest - MarketBeat
Achieve Life Sciences (ACHV) Appoints Interim Chief Medical Officer - GuruFocus
Achieve Life Sciences (ACHV) Appoints Interim Chief Medical Offi - GuruFocus
Achieve Life Sciences appoints Mark Rubinstein as interim CMO By Investing.com - Investing.com Canada
Achieve Life Sciences appoints Mark Rubinstein as interim CMO - Investing.com
Achieve Life Sciences (ACHV) Appoints New Interim Chief Medical Officer - GuruFocus
Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer - The Manila Times
Former UCSF Professor Takes CMO Role at Achieve Life Sciences Following FDA Filing Acceptance - Stock Titan
Achieve Life Sciences' nicotine dependence treatment under FDA review - MSN
Is Achieve Life Sciences Inc. stock influenced by commodity prices2025 Market Sentiment & Growth Oriented Trade Recommendations - Lancaster City Council
Xinos, Achieve Life Sciences CCO, sells $57,765 in ACHV stock By Investing.com - Investing.com Canada
Achieve Life Sciences Inc. Approaches Psychological Resistance LevelJuly 2025 Review & Growth Focused Stock Pick Reports - beatles.ru
Is Achieve Life Sciences Inc. a cyclical or defensive stockQuarterly Trade Review & Free Long-Term Investment Growth Plans - beatles.ru
Nantahala Capital Management LLC Has $2.40 Million Holdings in Achieve Life Sciences, Inc. $ACHV - MarketBeat
Volume spikes in Achieve Life Sciences Inc. stock – what they meanWeekly Market Outlook & Weekly High Return Stock Forecasts - Newser
Analyzing Achieve Life Sciences Inc. with risk reward ratio chartsJuly 2025 Trade Ideas & Stock Timing and Entry Methods - Newser
Exit strategy if you’re trapped in Achieve Life Sciences Inc.July 2025 Summary & Low Drawdown Trading Strategies - Newser
Is Achieve Life Sciences Inc. forming a breakout pattern2025 Key Highlights & Verified Short-Term Trading Plans - خودرو بانک
How institutional ownership impacts Achieve Life Sciences Inc. stock2025 Bull vs Bear & Growth-Oriented Investment Plans - Newser
Can trapped investors hope for a rebound in Achieve Life Sciences Inc.Market Growth Summary & Stock Portfolio Risk Control - Newser
News impact scoring models applied to Achieve Life Sciences Inc.IPO Watch & Verified Entry Point Detection - Newser
Comparing Achieve Life Sciences Inc. in custom built stock radars2025 Earnings Impact & Free Technical Pattern Based Buy Signals - Newser
Will Achieve Life Sciences Inc. see short term momentum - Newser
Is Achieve Life Sciences Inc. showing signs of accumulationJuly 2025 Decliners & Short-Term Trading Opportunity Alerts - Newser
Should you wait for a breakout in Achieve Life Sciences Inc.July 2025 Analyst Calls & Real-Time Market Sentiment Reports - Newser
Chart based analysis of Achieve Life Sciences Inc. trendsBull Run & Risk Managed Trade Strategies - Newser
Using portfolio simulators with Achieve Life Sciences Inc. included2025 Breakouts & Breakdowns & Community Shared Stock Ideas - Newser
Smart tools for monitoring Achieve Life Sciences Inc.’s price actionEarnings Risk Summary & Community Verified Watchlist Alerts - Newser
Achieve Life Sciences shares fall 1.75% premarket after FDA acceptance of cytisinicline NDA for smoking cessation. - AInvest
FDA accepts Achieve Life Sciences’ NDA for smoking cessation drug By Investing.com - Investing.com Canada
What is the target price for Achieve Life Sciences Inc. stockBuy Signal & Weekly High Conviction Ideas - خودرو بانک
Order flow analysis tools used on Achieve Life Sciences Inc.Weekly Gains Summary & Weekly Watchlist for Consistent Profits - Newser
Using flow based indicators on Achieve Life Sciences Inc.July 2025 Sentiment & Low Drawdown Momentum Trade Ideas - Newser
Achieve Life Sciences shares rise 1.36% after-hours after FDA acceptance of cytisinicline NDA for smoking cessation. - AInvest
Achieve Life Sciences Announces FDA Acceptance of Cytisinicline New Drug Application for Treatment of Nicotine Dependence for Smoking Cessation - MarketScreener
Achieve Life Sciences Inc Stock (ACHV) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.62%
0.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):